User menu

The role of the pathologist in tissue banking: European Consensus Expert Group Report

Bibliographic reference Bevilacqua, Generoso ; Bosman, Fred ; Dassesse, Thibaut ; Hoefler, Heinz ; Janin, Anne ; et. al. The role of the pathologist in tissue banking: European Consensus Expert Group Report. In: Virchows Archiv : an international journal of pathology, Vol. 456, no. 4, p. 449-454 (2010)
Permanent URL
  1. Riegman PH, Dinjens WN, Oosterhuis JW (2007) Biobanking for interdisciplinary clinical research. Pathobiology 74:239–244
  2. Riegman PH, Morente MM, Betsou F et al (2008) Biobanking for better healthcare. Mol Oncol 2:213–222
  3. Morente MM, Fernandez PL, de Alava E (2008) Biobanking: old activity or young discipline? Semin Diagn Pathol 25:317–322
  4. Asslaber M, Zatloukal K (2007) Biobanks: transnational, European and global networks. Brief Funct Genomic Proteomic 6:193–201
  5. Pukkala E, Andersen A, Berglund G et al (2007) Nordic biological specimen banks as basis for studies of cancer causes and control–more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol 46:286–307
  6. Ioannidis JP, Adami HO (2008) Nested randomized trials in large cohorts and biobanks: studying the health effects of lifestyle factors. Epidemiology 19:75–82
  7. Brand AM, Probst-Hensch NM (2007) Biobanking for epidemiological research and public health. Pathobiology 74:227–238
  8. Srivastava S, Gopal-Srivastava R (2002) Biomarkers in cancer screening: a public health perspective. J Nutr 132:2471S–2475S
  9. Srinivas PR, Kramer BS, Srivastava S (2001) Trends in biomarker research for cancer detection. Lancet Oncol 2:698–704
  10. Scheel JR, Kuo MD (2006) Exploring the human genome in cancer with genomic approaches. J Vasc Interv Radiol 17:1225–1233
  11. Rai AJ (2007) Biomarkers in translational research: focus on discovery, development and translation of protein biomarkers to clinical immunoassays. Expert Rev Mol Diagn 7:545–553
  12. Maruvada P, Wang W, Wagner PD et al (2005) Biomarkers in molecular medicine: cancer detection and diagnosis. Biotechniques Suppl:9–15
  13. Caboux E, Plymoth A, Hainaut P (2007) Common minimal technical standards and protocols for Biological Resource Centers dedicated to Cancer Research. IARC Working Group Reports 2:1–38
  14. Betsou F, Barnes R, Burke T et al (2009) Human biospecimen research: experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev 18:1017–1025
  15. Knoppers BM, Fortier I, Legault D et al (2008) The Public Population Project in Genomics (P3G): a proof of concept? Eur J Hum Genet 16:664–665
  16. Moore HM, Compton CC, Lim MD et al (2009) 2009 Biospecimen research network symposium: advancing cancer research through biospecimen science. Cancer Res 69:6770–6772
  17. Riegman PH, Dinjens WN, Oomen MH et al (2006) TuBaFrost 1: uniting local frozen tumour banks into a European network: an overview. Eur J Cancer 42:2678–2683
  18. Yuille M, van Ommen GJ, Brechot C et al (2008) Biobanking for Europe. Brief Bioinform 9:14–24
  19. Vaught JB, Lockhart N, Thiel KS et al (2007) Ethical, legal, and policy issues: dominating the biospecimen discussion. Cancer Epidemiol Biomarkers Prev 16:2521–2523
  20. Lemrow SM, Colditz GA, Vaught JB et al (2007) Key elements of access policies for biorepositories associated with population science research. Cancer Epidemiol Biomarkers Prev 16:1533–1535
  21. Van Veen EB, Riegman PH, Dinjens WN et al (2006) TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur J Cancer 42:2914–2923
  22. Riboli E (2001) The European Prospective Investigation into Cancer and Nutrition (EPIC): plans and progress. J Nutr 131:170S–175S